Impact of reducing complement inhibitor binding on the immunogenicity of native neisseria meningitidis outer membrane vesicles

Neisseria meningitidis recruits host human complement inhibitors to its surface to down-regulate complement activation and enhance survival in blood. We have investigated whether such complement inhibitor binding occurs after vaccination with native outer membrane vesicles (nOMVs), and limits immuno...

Полное описание

Библиографические подробности
Главные авторы: Daniels-Treffandier, H, de Nie, K, Marsay, L, Dold, C, Sadarangani, M, Reyes-Sandoval, A, Langford, P, Wyllie, D, Hill, F, Pollard, A, Rollier, C
Формат: Journal article
Язык:English
Опубликовано: Public Library of Science 2016
_version_ 1826300725183905792
author Daniels-Treffandier, H
de Nie, K
Marsay, L
Dold, C
Sadarangani, M
Reyes-Sandoval, A
Langford, P
Wyllie, D
Hill, F
Pollard, A
Rollier, C
author_facet Daniels-Treffandier, H
de Nie, K
Marsay, L
Dold, C
Sadarangani, M
Reyes-Sandoval, A
Langford, P
Wyllie, D
Hill, F
Pollard, A
Rollier, C
author_sort Daniels-Treffandier, H
collection OXFORD
description Neisseria meningitidis recruits host human complement inhibitors to its surface to down-regulate complement activation and enhance survival in blood. We have investigated whether such complement inhibitor binding occurs after vaccination with native outer membrane vesicles (nOMVs), and limits immunogenicity of such vaccines. To this end, nOMVs reactogenic lipopolysaccharide was detoxified by deletion of the lpxl1 gene (nOMVlpxl1). nOMVs unable to bind human complement factor H (hfH) were generated by additional deletions of the genes encoding factor H binding protein (fHbp) and neisserial surface protein A (NspA) (nOMVdis). Antibody responses elicited in mice with nOMVdis were compared to those elicited with nOMVlpxl1 in the presence of hfH. Results demonstrate that the administration of human fH to mice immunized with fHbp containing OMVlpxl1 decreased immunogenicity against fHbp (but not against the OMV as a whole). The majority of the OMV-induced bactericidal immune response (OMVlpxl1 or OMVdis) was versus PorA. Despite a considerable reduction of hfH binding to nOMVdis, and the absence of the vaccine antigen fHbp, immunogenicity in mice was not different from nOMVlpxl1, in the absence or presence of hfH (serum bactericidal titers of 1:64 vs 1:128 after one dose in the nOMVdis and nOMVlpxl1–immunized groups respectively). Therefore, partial inhibition of fH binding did not enhance immunity in this model.
first_indexed 2024-03-07T05:21:32Z
format Journal article
id oxford-uuid:df164994-7ee1-4b19-a7a3-2df1ac62e9d6
institution University of Oxford
language English
last_indexed 2024-03-07T05:21:32Z
publishDate 2016
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:df164994-7ee1-4b19-a7a3-2df1ac62e9d62022-03-27T09:36:51ZImpact of reducing complement inhibitor binding on the immunogenicity of native neisseria meningitidis outer membrane vesiclesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:df164994-7ee1-4b19-a7a3-2df1ac62e9d6EnglishSymplectic Elements at OxfordPublic Library of Science2016Daniels-Treffandier, Hde Nie, KMarsay, LDold, CSadarangani, MReyes-Sandoval, ALangford, PWyllie, DHill, FPollard, ARollier, CNeisseria meningitidis recruits host human complement inhibitors to its surface to down-regulate complement activation and enhance survival in blood. We have investigated whether such complement inhibitor binding occurs after vaccination with native outer membrane vesicles (nOMVs), and limits immunogenicity of such vaccines. To this end, nOMVs reactogenic lipopolysaccharide was detoxified by deletion of the lpxl1 gene (nOMVlpxl1). nOMVs unable to bind human complement factor H (hfH) were generated by additional deletions of the genes encoding factor H binding protein (fHbp) and neisserial surface protein A (NspA) (nOMVdis). Antibody responses elicited in mice with nOMVdis were compared to those elicited with nOMVlpxl1 in the presence of hfH. Results demonstrate that the administration of human fH to mice immunized with fHbp containing OMVlpxl1 decreased immunogenicity against fHbp (but not against the OMV as a whole). The majority of the OMV-induced bactericidal immune response (OMVlpxl1 or OMVdis) was versus PorA. Despite a considerable reduction of hfH binding to nOMVdis, and the absence of the vaccine antigen fHbp, immunogenicity in mice was not different from nOMVlpxl1, in the absence or presence of hfH (serum bactericidal titers of 1:64 vs 1:128 after one dose in the nOMVdis and nOMVlpxl1–immunized groups respectively). Therefore, partial inhibition of fH binding did not enhance immunity in this model.
spellingShingle Daniels-Treffandier, H
de Nie, K
Marsay, L
Dold, C
Sadarangani, M
Reyes-Sandoval, A
Langford, P
Wyllie, D
Hill, F
Pollard, A
Rollier, C
Impact of reducing complement inhibitor binding on the immunogenicity of native neisseria meningitidis outer membrane vesicles
title Impact of reducing complement inhibitor binding on the immunogenicity of native neisseria meningitidis outer membrane vesicles
title_full Impact of reducing complement inhibitor binding on the immunogenicity of native neisseria meningitidis outer membrane vesicles
title_fullStr Impact of reducing complement inhibitor binding on the immunogenicity of native neisseria meningitidis outer membrane vesicles
title_full_unstemmed Impact of reducing complement inhibitor binding on the immunogenicity of native neisseria meningitidis outer membrane vesicles
title_short Impact of reducing complement inhibitor binding on the immunogenicity of native neisseria meningitidis outer membrane vesicles
title_sort impact of reducing complement inhibitor binding on the immunogenicity of native neisseria meningitidis outer membrane vesicles
work_keys_str_mv AT danielstreffandierh impactofreducingcomplementinhibitorbindingontheimmunogenicityofnativeneisseriameningitidisoutermembranevesicles
AT deniek impactofreducingcomplementinhibitorbindingontheimmunogenicityofnativeneisseriameningitidisoutermembranevesicles
AT marsayl impactofreducingcomplementinhibitorbindingontheimmunogenicityofnativeneisseriameningitidisoutermembranevesicles
AT doldc impactofreducingcomplementinhibitorbindingontheimmunogenicityofnativeneisseriameningitidisoutermembranevesicles
AT sadaranganim impactofreducingcomplementinhibitorbindingontheimmunogenicityofnativeneisseriameningitidisoutermembranevesicles
AT reyessandovala impactofreducingcomplementinhibitorbindingontheimmunogenicityofnativeneisseriameningitidisoutermembranevesicles
AT langfordp impactofreducingcomplementinhibitorbindingontheimmunogenicityofnativeneisseriameningitidisoutermembranevesicles
AT wyllied impactofreducingcomplementinhibitorbindingontheimmunogenicityofnativeneisseriameningitidisoutermembranevesicles
AT hillf impactofreducingcomplementinhibitorbindingontheimmunogenicityofnativeneisseriameningitidisoutermembranevesicles
AT pollarda impactofreducingcomplementinhibitorbindingontheimmunogenicityofnativeneisseriameningitidisoutermembranevesicles
AT rollierc impactofreducingcomplementinhibitorbindingontheimmunogenicityofnativeneisseriameningitidisoutermembranevesicles